AVAVA, LLC announced that it will issue will issue 2,377,179 shares at a price of $6.31 per share for gross proceeds of $14,999,9999.49 on April 4, 2024. The transaction will include participation from new investor Jeisys Medical Inc. The company will issue shares through third party allocation paid-in capital increase. The transaction has been approved by board of directors of the company.

The transaction is expected to close on April 9, 2024.